Cargando…

Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients

BACKGROUND: Atopic dermatitis (AD) is a chronic, inflammatory cutaneous disorder characterized by a T helper 2 (Th2) immune response phenotype. Extracellular vesicles (EVs) are a heterogeneous family of cell-derived membranous structures, which transport cellular components such as DNA and proteins,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chih-Jung, Wang, Hai-Qing, Zhang, Jing, Zou, Ying, Zhang, Yi-Hua, Chen, Jia-Wen, Chen, Chun-Bing, Chung, Wen-Hung, Ji, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403561/
https://www.ncbi.nlm.nih.gov/pubmed/34471367
http://dx.doi.org/10.2147/CCID.S325515
_version_ 1783746024716632064
author Chang, Chih-Jung
Wang, Hai-Qing
Zhang, Jing
Zou, Ying
Zhang, Yi-Hua
Chen, Jia-Wen
Chen, Chun-Bing
Chung, Wen-Hung
Ji, Chao
author_facet Chang, Chih-Jung
Wang, Hai-Qing
Zhang, Jing
Zou, Ying
Zhang, Yi-Hua
Chen, Jia-Wen
Chen, Chun-Bing
Chung, Wen-Hung
Ji, Chao
author_sort Chang, Chih-Jung
collection PubMed
description BACKGROUND: Atopic dermatitis (AD) is a chronic, inflammatory cutaneous disorder characterized by a T helper 2 (Th2) immune response phenotype. Extracellular vesicles (EVs) are a heterogeneous family of cell-derived membranous structures, which transport cellular components such as DNA and proteins, and are involved in multiple physiological and pathological processes. Increasing evidence has shown that EVs secretion took part in the pathogenesis of AD. However, the proteomic studies of plasma-derived EVs in AD patients have not been reported. OBJECTIVE: In this study, we investigated the diversity of plasma EVs collected from AD patients and healthy individuals and suggested that the candidates for uniquely or differentially expressed proteins in plasma EVs could be a diagnostic marker in AD. METHODS: The plasma EVs were collected from 12 patients with moderate-to-severe AD and 13 healthy subjects. Proteomic analysis was performed by using a comprehensive nanoLC‑MS/MS method. RESULTS: Proteomic analysis revealed that a total of 1478 proteins in plasma EVs were found to be common proteins in AD, whereas a total of 1597 proteins in plasma EVs were found to be common proteins in HC. Eighty-six proteins in plasma EVs showed more than 2.5-fold up-regulation, while a total of 225 proteins in plasma EVs showed less than 1/2.5-fold down-regulation with a significant difference (p < 0.05) among AD compared with HC. The candidates for differentially expressed proteins in plasma EVs have been described as a connectivity PPI network related to several KEGG pathways, including pathways in platelet activation, complement, and so on. CONCLUSION: SLP-76 tyrosine phosphoprotein (SLP76) involved in platelet activation may significantly contribute to the pathogenesis of AD. We will further verify the role of SLP67 in AD via animal and cell experiments to provide a promising therapeutic or diagnostic target.
format Online
Article
Text
id pubmed-8403561
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84035612021-08-31 Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients Chang, Chih-Jung Wang, Hai-Qing Zhang, Jing Zou, Ying Zhang, Yi-Hua Chen, Jia-Wen Chen, Chun-Bing Chung, Wen-Hung Ji, Chao Clin Cosmet Investig Dermatol Original Research BACKGROUND: Atopic dermatitis (AD) is a chronic, inflammatory cutaneous disorder characterized by a T helper 2 (Th2) immune response phenotype. Extracellular vesicles (EVs) are a heterogeneous family of cell-derived membranous structures, which transport cellular components such as DNA and proteins, and are involved in multiple physiological and pathological processes. Increasing evidence has shown that EVs secretion took part in the pathogenesis of AD. However, the proteomic studies of plasma-derived EVs in AD patients have not been reported. OBJECTIVE: In this study, we investigated the diversity of plasma EVs collected from AD patients and healthy individuals and suggested that the candidates for uniquely or differentially expressed proteins in plasma EVs could be a diagnostic marker in AD. METHODS: The plasma EVs were collected from 12 patients with moderate-to-severe AD and 13 healthy subjects. Proteomic analysis was performed by using a comprehensive nanoLC‑MS/MS method. RESULTS: Proteomic analysis revealed that a total of 1478 proteins in plasma EVs were found to be common proteins in AD, whereas a total of 1597 proteins in plasma EVs were found to be common proteins in HC. Eighty-six proteins in plasma EVs showed more than 2.5-fold up-regulation, while a total of 225 proteins in plasma EVs showed less than 1/2.5-fold down-regulation with a significant difference (p < 0.05) among AD compared with HC. The candidates for differentially expressed proteins in plasma EVs have been described as a connectivity PPI network related to several KEGG pathways, including pathways in platelet activation, complement, and so on. CONCLUSION: SLP-76 tyrosine phosphoprotein (SLP76) involved in platelet activation may significantly contribute to the pathogenesis of AD. We will further verify the role of SLP67 in AD via animal and cell experiments to provide a promising therapeutic or diagnostic target. Dove 2021-08-25 /pmc/articles/PMC8403561/ /pubmed/34471367 http://dx.doi.org/10.2147/CCID.S325515 Text en © 2021 Chang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chang, Chih-Jung
Wang, Hai-Qing
Zhang, Jing
Zou, Ying
Zhang, Yi-Hua
Chen, Jia-Wen
Chen, Chun-Bing
Chung, Wen-Hung
Ji, Chao
Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients
title Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients
title_full Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients
title_fullStr Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients
title_full_unstemmed Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients
title_short Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients
title_sort distinct proteomic profiling of plasma extracellular vesicles from moderate-to-severe atopic dermatitis patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403561/
https://www.ncbi.nlm.nih.gov/pubmed/34471367
http://dx.doi.org/10.2147/CCID.S325515
work_keys_str_mv AT changchihjung distinctproteomicprofilingofplasmaextracellularvesiclesfrommoderatetosevereatopicdermatitispatients
AT wanghaiqing distinctproteomicprofilingofplasmaextracellularvesiclesfrommoderatetosevereatopicdermatitispatients
AT zhangjing distinctproteomicprofilingofplasmaextracellularvesiclesfrommoderatetosevereatopicdermatitispatients
AT zouying distinctproteomicprofilingofplasmaextracellularvesiclesfrommoderatetosevereatopicdermatitispatients
AT zhangyihua distinctproteomicprofilingofplasmaextracellularvesiclesfrommoderatetosevereatopicdermatitispatients
AT chenjiawen distinctproteomicprofilingofplasmaextracellularvesiclesfrommoderatetosevereatopicdermatitispatients
AT chenchunbing distinctproteomicprofilingofplasmaextracellularvesiclesfrommoderatetosevereatopicdermatitispatients
AT chungwenhung distinctproteomicprofilingofplasmaextracellularvesiclesfrommoderatetosevereatopicdermatitispatients
AT jichao distinctproteomicprofilingofplasmaextracellularvesiclesfrommoderatetosevereatopicdermatitispatients